Best Healthcare Companies in Hangzhou, China
The 71 best Healthcare companies in Hangzhou, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Huadong Medicine.
Ranked: Best Healthcare companies in Hangzhou
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Huadong Medicine Manufacturer of pharmaceutical products | $532M | 124 mo ago | Public | 14,061 | Liang Lu CEO | — | — |
| 2 | Innoforce Pharmaceuticals Manufacturer of biopharmaceuticals | $179M | 54 mo ago | Series A | 2 | Yuling Li Founder & CEO | — | — |
| 3 | Hangzhou multi Jubilee Biotechnology Provider of drug research and development services | $155M | 61 mo ago | Series C | 98 | — | — | — |
| 4 | Bang Er Chain of Orthopedic hospitals | $136M | 65 mo ago | Series D | 3,000 | — | — | — |
| 5 | Aidikang Medical Laboratory Center Chain of pathology labs | $88M | 64 mo ago | Public | 5,917 | — | — | — |
| 6 | Zhejiang Mingdu Zhikong Technology Provider of AI based logistics services | $73M | 27 mo ago | Series C | 500 | Wang Lijun CEO | — | — |
| 7 | SAINT BELLA Postpartum care brand offering maternity and baby care products | $31M | 34 mo ago | Public | — | Danny Xiang Founder & CEO | Animate.cssVue.jsjQuery+6 | — |
| 8 | Zhejiang Shimai Pharmaceutical Manufacturer of drugs for multiple therapeutic areas | $22M | 53 mo ago | Series C | — | Weizao Chen CEO | DreamWeaverApache HTTP ServerjQuery | — |
| 9 | Hangzhou Changxi Provider of inhalation drug delivery platform services to pharma companies | $21M | 72 mo ago | Deadpooled | — | Huang Peng Co-founder & Vice President | — | — |
| 10 | Chain Medical Labs Medical lab offering clinical lab testing, clinical trial and research services | $21M | 98 mo ago | Series B | — | Yao Guo CEO | — | — |
| 11 | Jo-Jo Drugstores Provider of diversified pharmaceutical products and services | $20M | 72 mo ago | Public | 938 | Lei Liu CEO | — | — |
| 12 | Pilot gene technology R&D, producer, and supplier of digital PCR products | $19M | 59 mo ago | Series A | 50 | — | — | — |
| 13 | West Lake R&D company focused on manufacturing of drugs for multiple diseases | $15M | 59 mo ago | Series A | — | Gao Xiaofei Founder | — | — |
| 14 | Dian Diagnostics Sale, outsourcing, research and development of medical diagnostic product and services | $15M | 201 mo ago | Series A | 13,128 | Haibin Chen Founder | — | — |
| 15 | Vivachek Biotech Manufacturer of blood glucose meter | $14M | 78 mo ago | Series C | — | — | — | 1 partnership |
| 16 | Xinzeyuan Medical Technology Provider of medical accessories and medical device consumables | $14M | 17 mo ago | Series B | 300 | — | — | — |
| 17 | Rebeccamed Developer of non-silicon based micro/nanomaterials | $10M | 28 mo ago | Series A | — | Yang Zhang Founder & CEO | — | — |
| 18 | China Senior Care Chain of senior care facilities | $10M | 164 mo ago | Deadpooled | — | Mark Spitalnik CEO | — | — |
| 19 | Hangzhou Proprium Biotech R&D company manufacturing molecular diagnostics biomarkers, assays, and devices | $9M | 73 mo ago | Series A | — | Bill Lin CEO | — | — |
| 20 | CarbonSilicon Provider of AI computing solutions for drug research & development services | $7M | 45 mo ago | Seed | — | Shi Hui Co-Founder | — | — |
| 21 | Hangzhou Songyang Biological Technology Manufacturer of stretch mark repair and prevention products | $2M | 77 mo ago | Series A | — | Chen Jianguo Founder | — | — |
Top 12 Healthcare companies in Hangzhou
#1
Series B · Hangzhou, Zhejiang · founded 2010 · 300 employees$13.8Mraised▾
Hangzhou Xinzeyuan Medical Technology Co., Ltd. is focused on providing medical accessories and precision products. Their solutions cater to medical equipment needs and supply chain solutions within the medical industry.
- Jan 2025Series B$14M
- Jul 2024Series B$13.8M
#2
Series C · Hangzhou, Zhejiang · founded 2017 · 500 employees$73.1Mraised▾
Provider of AI based logistics services
- Feb 2024Series C—
- May 2021Series B$47.1M
- Jul 2020Series A$11.4M
- Jul 2019Series A$14.5M
#3
Series A · Hangzhou, Zhejiang · founded 2018$10Mraised▾
Rebeccamed is a developer of 3D non-silicon based micro/nano technology products. The company has developed micro-nano sensors, brakes, and micro-system sample for developing micro-high-energy relays, ultra-thin microphones, and minimally invasive catheters.
- Feb 2024Series A$10M
- 2020Series A—
#4
Public · Hangzhou, Zhejiang · founded 2017$30.6Mraised▾
SAINT BELLA is a high-end postpartum care brand offering luxury maternity services, known for its art therapy approach. Established in 2017, SAINT BELLA provides exclusive customer service and collaborations in the maternity and baby care sector.
- Jul 2023Series C—
- Mar 2022Series C—
- Mar 2021Series C$30.6M
- Mar 2020Series B—
#5
Series A · Hangzhou, Zhejiang · founded 2018 · 2 employees$179Mraised▾
Manufacturer of biopharmaceuticals
- Dec 2021Series A$59M
- Mar 2021Series A$96M
- Jun 2020Seed$24M
#6
Series D · Hangzhou, Zhejiang · founded 1989 · 3000 employees$135.9Mraised▾
Chain of Orthopedic hospitals
- Jan 2021Series D$46.3M
- May 2018Series C$47.1M
- Jan 2017Series B$29.1M
- Oct 2014Series A$13.5M
#7
Series C · Hangzhou, Zhejiang · founded 2012 · 98 employees$155.4Mraised▾
Provider of drug research and development services
- May 2021Series C$155.4M
#8
Public · Hangzhou, Zhejiang · founded 1993 · 14061 employees$532Mraised▾
Huadong Medicine is engaged in the pharmaceutical manufacturing. The Company operates its principal business through manufacture of medicines as well as trading of medicines. The Company’s products consist of Chinese medicine products, immunosuppressive preparations, diabetes drugs, drugs for digestive system diseases, blood drugs, drugs for bone injuries and active pharmaceutical ingredients, among others. The Company also involves in the medical equipment business. It markets its products in domestic and overseas markets.
- Feb 2016Post IPO$532M
#9
Public · Hangzhou, Zhejiang · founded 2004 · 5917 employees$88Mraised▾
Chain of pathology labs
- Jan 2021Series C$88M
- Oct 2018Series B—
#10
Series C · Hangzhou, Zhejiang · founded 2017$22Mraised▾
Manufacturer of drugs for multiple therapeutic areas
- Jan 2022Series C—
- Sep 2020Series B$22M
#11
Seed · Hangzhou, Zhejiang · founded 2022$7.2Mraised▾
Provider of AI computing solutions for drug research & development services
- Sep 2022Angel$7.2M
#12
Series A · Hangzhou, Zhejiang · founded 2017 · 50 employees$18.5Mraised▾
Developer of a digital polymerase chain reaction (PCR) system intended to provide an absolute method of quantification of target DNA or RNA molecules with accuracy and sensitivity. The company's system is based on microfluidic technology digital PCR, which automatically completes the steps of nucleic acid extraction, sample generation, sample amplification, sample detection, data analysis, enabling seamless integration with the two modules of nucleic acid extraction and ddPCR amplification.
- Jul 2021Series A$18.5M
- Angel—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.